Applied dna and evvivax to launch clinical trial for veterinary use of linear covid-19 vaccine candidate

Applied dna and takis biotech/evvivax to launch clinical trial for veterinary use of linear covid-19 vaccine candidate.domestic feline companion animals may serve as reservoir for sars-cov-2 infections in humans.applied dna -clinical trial is single-center trial that intends to enroll 30 healthy domestic feline companion animals & follow them for 6 months.
APDN Ratings Summary
APDN Quant Ranking